Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
The UP Study results
Preclinical data have suggested that the bile acid Ursodeoxycholic acid (or UDCA) has neuroprotective properties in models of Parkinson’s. Researchers in Sheffield have led much of this research and they have also been coordinating a clinical trial assessing this molecule in people with Parkinson’s. The study was called the “UDCA in […]
Bonhams sale of Romanée-Conti 2002 in support of Cure Parkinson’s
Cure Parkinson’s is delighted that Bonhams will be auctioning a six-bottle case of Romanee-Conti 2002, Domaine de la Romanée-Conti at its Fine Wines & Spirits Sale in London on Thursday 6 July 2023. The six-bottle case of Romanee-Conti 2002, with an estimated value of £100,000…
Positively Parkinson’s return with the Big Tri 2023
The Big Tri will see the Positively Parkinson’s team take on an epic swim, cycle and hike to raise vital funds for Cure Parkinson’s. Back in 2021, 12 members of Positively Parkinson’s (including three living with Parkinson’s) swam across the Solent to the Isle of…
Parkinson’s drug therapies in the clinical trial pipeline: 2023 update
Cure Parkinson’s has collaborated annually with Parkinson’s advocates and the Michael J Fox Foundation to present an update on the clinical trials landscape for Parkinson’s. The 2023 report is now published.
Phase 2 UDCA in Parkinson’s trial results published
Cure Parkinson’s is excited to announce that the results from the ‘UP Study’ – a phase 2 study of the liver drug UDCA in Parkinson’s – will be published in the academic journal Movement Disorders.